Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 7.67%261.79M | -1.26%235.57M | -1.26%235.57M | 1.22%232.88M | 3.48%231.53M | 4.67%243.14M | 0.43%238.57M | 0.43%238.57M | -6.69%230.07M | -10.11%223.75M |
-Cash and cash equivalents | 56.24%64.67M | -16.95%48.88M | -16.95%48.88M | 9.45%45.08M | 189.24%69.63M | -27.25%41.39M | -26.22%58.85M | -26.22%58.85M | -83.29%41.19M | -90.33%24.07M |
-Short-term investments | -2.30%197.13M | 3.88%186.69M | 3.88%186.69M | -0.57%187.8M | -18.92%161.91M | 15.02%201.76M | 13.91%179.72M | 13.91%179.72M | --188.88M | --199.68M |
Receivables | 55.08%11.03M | 13.40%8.96M | 13.40%8.96M | 60.55%9.34M | 111.39%9.06M | 84.42%7.12M | 121.89%7.9M | 121.89%7.9M | 110.72%5.82M | 82.69%4.29M |
-Accounts receivable | 55.08%11.03M | 13.40%8.96M | 13.40%8.96M | 60.55%9.34M | 111.39%9.06M | 84.42%7.12M | 121.89%7.9M | 121.89%7.9M | 110.72%5.82M | 82.69%4.29M |
Current deferred assets | 5.70%10.16M | 10.69%10.04M | 10.69%10.04M | 19.08%9.76M | 31.52%9.74M | 36.18%9.61M | 30.11%9.07M | 30.11%9.07M | 11.27%8.19M | 1.76%7.4M |
Other current assets | -14.50%14.46M | 115.87%21.62M | 115.87%21.62M | 24.54%20.43M | 79.12%30.27M | 42.03%16.91M | 7.60%10.01M | 7.60%10.01M | 158.72%16.4M | 61.18%16.9M |
Total current assets | 7.46%297.45M | 4.00%276.18M | 4.00%276.18M | 4.58%272.41M | 11.20%280.6M | 8.49%276.79M | 3.18%265.55M | 3.18%265.55M | -0.96%260.49M | -6.20%252.34M |
Non current assets | ||||||||||
Net PPE | 1.70%18.53M | -14.91%17.66M | -14.91%17.66M | 10.03%18.27M | 8.38%19.21M | -0.16%18.22M | 3.34%20.76M | 3.34%20.76M | 137.70%16.6M | 105.31%17.72M |
-Gross PPE | 12.22%31.39M | 0.06%29.6M | 0.06%29.6M | 19.31%29.56M | 18.30%29.62M | 13.40%27.97M | 15.28%29.59M | 15.28%29.59M | 106.35%24.77M | 74.76%25.04M |
-Accumulated depreciation | -31.87%-12.86M | -35.24%-11.94M | -35.24%-11.94M | -38.17%-11.29M | -42.32%-10.42M | -52.00%-9.75M | -58.25%-8.83M | -58.25%-8.83M | -62.73%-8.17M | -28.48%-7.32M |
Goodwill and other intangible assets | 117.52%90.69M | 115.31%88.19M | 115.31%88.19M | 312.06%85.05M | 236.85%67.58M | 118.67%41.69M | 143.60%40.96M | 143.60%40.96M | 17.33%20.64M | 10.94%20.06M |
-Goodwill | 132.99%57.68M | 125.65%56.14M | 125.65%56.14M | 601.72%54.3M | 417.38%40.63M | 218.79%24.76M | 281.05%24.88M | 281.05%24.88M | 22.11%7.74M | 16.51%7.85M |
-Other intangible assets | 94.89%33.01M | 99.31%32.06M | 99.31%32.06M | 138.32%30.75M | 120.72%26.95M | 49.86%16.94M | 56.36%16.08M | 56.36%16.08M | 14.63%12.9M | 7.63%12.21M |
Non current deferred assets | -3.04%3.38M | -14.11%3.08M | -14.11%3.08M | -14.64%2.72M | 16.84%3M | 59.35%3.49M | 72.24%3.59M | 72.24%3.59M | 30.54%3.19M | -0.81%2.57M |
Other non current assets | 318.48%6.45M | 820.22%5.83M | 820.22%5.83M | 412.44%5.36M | 113.64%2.57M | 79.09%1.54M | -72.82%633K | -72.82%633K | -72.12%1.05M | -69.34%1.2M |
Total non current assets | 83.32%119.06M | 74.05%114.76M | 74.05%114.76M | 168.56%111.39M | 122.26%92.35M | 60.88%64.94M | 59.61%65.94M | 59.61%65.94M | 34.81%41.48M | 25.07%41.55M |
Total assets | 21.88%416.5M | 17.94%390.94M | 17.94%390.94M | 27.10%383.8M | 26.90%372.95M | 15.64%341.73M | 10.98%331.49M | 10.98%331.49M | 2.78%301.96M | -2.76%293.89M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 16.44%28.11M | 2.88%21.29M | 2.88%21.29M | 18.08%23.21M | 35.76%26.76M | 4.14%24.14M | -22.46%20.69M | -22.46%20.69M | -16.37%19.65M | 37.55%19.71M |
-accounts payable | 39.95%14.22M | 13.89%10.46M | 13.89%10.46M | 16.53%11.54M | 9.30%11.2M | -10.67%10.16M | -40.71%9.19M | -40.71%9.19M | -24.70%9.9M | 78.84%10.25M |
-Total tax payable | -0.65%13.89M | -5.91%10.83M | -5.91%10.83M | 19.66%11.67M | 64.40%15.56M | 18.41%13.98M | 2.81%11.51M | 2.81%11.51M | -5.77%9.75M | 10.04%9.47M |
Current accrued expenses | 48.82%189K | 103.16%193K | 103.16%193K | -17.82%83K | -63.77%75K | -15.89%127K | -52.74%95K | -52.74%95K | -93.58%101K | -97.92%207K |
Current provisions | 29.05%1.04M | -4.19%526K | -4.19%526K | -10.30%871K | -44.34%949K | -29.90%802K | -59.99%549K | -59.99%549K | -39.58%971K | 3.84%1.71M |
Current debt and capital lease obligation | 25.56%5.2M | 9.24%4.67M | 9.24%4.67M | 28.41%4.77M | 28.09%4.83M | 13.20%4.14M | 15.70%4.27M | 15.70%4.27M | --3.71M | --3.77M |
-Current capital lease obligation | 25.56%5.2M | 9.24%4.67M | 9.24%4.67M | 28.41%4.77M | 28.09%4.83M | 13.20%4.14M | 15.70%4.27M | 15.70%4.27M | --3.71M | --3.77M |
Current deferred liabilities | 24.91%79.93M | 23.18%71.83M | 23.18%71.83M | 24.90%69M | 19.04%66.59M | 13.74%63.99M | 18.15%58.31M | 18.15%58.31M | 17.23%55.24M | 15.80%55.94M |
Other current liabilities | 117.64%5.75M | 145.40%6.91M | 145.40%6.91M | 297.34%7.46M | 215.26%7.6M | 6.58%2.64M | 21.90%2.82M | 21.90%2.82M | -29.50%1.88M | -8.01%2.41M |
Current liabilities | 26.04%126.7M | 20.75%114.09M | 20.75%114.09M | 27.51%113.05M | 26.09%112.01M | 8.10%100.53M | 6.51%94.48M | 6.51%94.48M | 10.02%88.66M | 8.38%88.83M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -6.35%8.57M | -26.42%7.6M | -26.42%7.6M | -7.17%7.32M | -0.50%8.08M | 13.78%9.15M | 15.70%10.33M | 15.70%10.33M | --7.88M | --8.13M |
-Long term capital lease obligation | -6.35%8.57M | -26.42%7.6M | -26.42%7.6M | -7.17%7.32M | -0.50%8.08M | 13.78%9.15M | 15.70%10.33M | 15.70%10.33M | --7.88M | --8.13M |
Non current deferred liabilities | 99.04%1.87M | 58.63%1.86M | 58.63%1.86M | 406.99%2.18M | 497.52%2.17M | 271.15%939K | 779.70%1.17M | 779.70%1.17M | -12.98%429K | 73.68%363K |
Other non current liabilities | 1,695.52%1.2M | -12.55%1.05M | -12.55%1.05M | 900.44%2.26M | 127.60%1.53M | -91.14%67K | 16.81%1.2M | 16.81%1.2M | -84.20%226K | -69.07%674K |
Total non current liabilities | 14.62%11.64M | -17.27%10.5M | -17.27%10.5M | 37.68%11.75M | 28.65%11.79M | 12.21%10.16M | 25.89%12.7M | 25.89%12.7M | 343.84%8.54M | 283.67%9.16M |
Total liabilities | 24.99%138.34M | 16.25%124.59M | 16.25%124.59M | 28.41%124.8M | 26.33%123.79M | 8.46%110.68M | 8.49%107.18M | 8.49%107.18M | 17.80%97.19M | 16.18%98M |
Shareholders'equity | ||||||||||
Share capital | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K |
-common stock | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K |
-Preferred stock | ---- | --0 | --0 | ---- | ---- | ---- | --0 | --0 | --0 | --0 |
Retained earnings | 9.94%-62.91M | 11.44%-63.76M | 11.44%-63.76M | 14.92%-67.11M | 17.92%-68.2M | 15.64%-69.86M | 1.30%-72M | 1.30%-72M | -33.57%-78.87M | -66.32%-83.09M |
Paid-in capital | 11.44%331.92M | 10.51%322.59M | 10.51%322.59M | 9.83%313.92M | 8.86%306.1M | 7.46%297.86M | 6.51%291.9M | 6.51%291.9M | 5.17%285.83M | 4.45%281.18M |
Gains losses not affecting retained earnings | 84.30%-311K | -195.35%-2.22M | -195.35%-2.22M | 177.59%1.7M | -3.63%-2.28M | -114.39%-1.98M | 37.65%-752K | 37.65%-752K | -50.07%-2.19M | -63.14%-2.2M |
Total stockholders'equity | 18.88%268.69M | 17.09%256.6M | 17.09%256.6M | 21.37%248.52M | 20.28%235.62M | 16.83%226.02M | 9.63%219.15M | 9.63%219.15M | -3.08%204.77M | -10.10%195.89M |
Noncontrolling interests | 88.11%9.46M | 88.70%9.75M | 88.70%9.75M | --10.48M | --13.54M | --5.03M | --5.17M | --5.17M | ---- | ---- |
Total equity | 20.39%278.16M | 18.74%266.35M | 18.74%266.35M | 26.48%259M | 27.19%249.16M | 19.43%231.05M | 12.21%224.32M | 12.21%224.32M | -3.08%204.77M | -10.10%195.89M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |